Presentation is loading. Please wait.

Presentation is loading. Please wait.

William V. Sharp, M. D. , Steven P. Schmidt, Ph. D. , Duane L

Published byWerner Glöckner Modified over 6 years ago

Similar presentations

Presentation on theme: "William V. Sharp, M. D. , Steven P. Schmidt, Ph. D. , Duane L"— Presentation transcript:

1 Prostaglandin biochemistry of seeded endothelial cells on Dacron prostheses 
William V. Sharp, M.D., Steven P. Schmidt, Ph.D., Duane L. Donovan, M.D.  Journal of Vascular Surgery  Volume 3, Issue 2, Pages (February 1986) DOI: / (86) Copyright © 1986 Society for Vascular Surgery and North American Chapter, International Society for Cardiovascular Surgery Terms and Conditions

2 Fig. 2 Patency and thrombus-free surface area of non-endothelial cell-seeded grafts. NM = nonmedicated; A/Di = aspirin (300 mg)/dipyridamole (50 mg twice daily); A/h = high-dose aspirin (300 mg daily); A/l = low-dose aspirin (75 mg every other day); U-5 = U-53,059 (3 mg/kg daily); Ibu =1buprofen (10 mg/kg daily); Dip = dipyridamole (50 mg twice daily); U-6 = U-63557A (10 mg/kg daily); TFS = thrombus-free surface. Journal of Vascular Surgery 1986 3, DOI: ( / (86) ) Copyright © 1986 Society for Vascular Surgery and North American Chapter, International Society for Cardiovascular Surgery Terms and Conditions

3 Fig. 3 Patency and thrombus-free surface area of endothelial cell-seeded grafts. For legend see Fig. 2. Journal of Vascular Surgery 1986 3, DOI: ( / (86) ) Copyright © 1986 Society for Vascular Surgery and North American Chapter, International Society for Cardiovascular Surgery Terms and Conditions

4 Fig. 4 Mean PGI2 production by 4 mm biopsy punches (seeded vs. nonseeded graft). N = nonmedicated; U6 = U-63557A; Ah = high-dose aspirin; Al = low-dose aspirin; AD = aspirin/dipyridamole; D = dipyridamole; Ib = ibuprofen; U5 = U-53,059. Journal of Vascular Surgery 1986 3, DOI: ( / (86) ) Copyright © 1986 Society for Vascular Surgery and North American Chapter, International Society for Cardiovascular Surgery Terms and Conditions

5 Fig. 5 Mean PGI2 production by 4 mm biopsy punches (normal carotid artery). For legend see Fig. 2. Journal of Vascular Surgery 1986 3, DOI: ( / (86) ) Copyright © 1986 Society for Vascular Surgery and North American Chapter, International Society for Cardiovascular Surgery Terms and Conditions

6 Fig. 6 TxB2 production by patent seeded and nonseeded Dacron grafts. For legend see Fig. 2. Journal of Vascular Surgery 1986 3, DOI: ( / (86) ) Copyright © 1986 Society for Vascular Surgery and North American Chapter, International Society for Cardiovascular Surgery Terms and Conditions

Download ppt "William V. Sharp, M. D. , Steven P. Schmidt, Ph. D. , Duane L"

Similar presentations

Timing of carotid endarterectomy after acute stroke Joseph J. Plotrowski, MD, Victor M. Bernhard, MD, Jeffrey R. Rubin, MD, Kenneth E. McIntyre, MD, James.

Timing of carotid endarterectomy after acute stroke Joseph J. Plotrowski, MD, Victor M. Bernhard, MD, Jeffrey R. Rubin, MD, Kenneth E. McIntyre, MD, James.
Endothelial cell seeding reduces thrombogenicity of Dacron grafts in humans Per Örtenwall, MD, PhD *, Hans Wadenvik, MD, PhD **, Jack Kutti, MD, PhD **,

Endothelial cell seeding reduces thrombogenicity of Dacron grafts in humans Per Örtenwall, MD, PhD *, Hans Wadenvik, MD, PhD **, Jack Kutti, MD, PhD **,
The role of arteriovenous shunts in the pathogenesis of varicose veins Howard C. Baron, M.D., Sebastiano Cassaro, M.D. Journal of Vascular Surgery Volume.

The role of arteriovenous shunts in the pathogenesis of varicose veins Howard C. Baron, M.D., Sebastiano Cassaro, M.D. Journal of Vascular Surgery Volume.
Platelet survival and serotonin content after placement of arterial prostheses in dogs: Effects of neointimal coverage and high- and low-dose aspirin G.Patrick.

Platelet survival and serotonin content after placement of arterial prostheses in dogs: Effects of neointimal coverage and high- and low-dose aspirin G.Patrick.
The effect of inguinal lymphatic manipulation on regional lymph flow patterns Jeffrey R. Rubin, MD, Lisa B. Eberlin, MD Journal of Vascular Surgery Volume.

The effect of inguinal lymphatic manipulation on regional lymph flow patterns Jeffrey R. Rubin, MD, Lisa B. Eberlin, MD Journal of Vascular Surgery Volume.
Shunya Shindo, M. D. , Atsuhiko Takagi, M. D. , Anthony D

Shunya Shindo, M. D. , Atsuhiko Takagi, M. D. , Anthony D
A review of 100 consecutive reconstructions of the distal vertebral artery for embolic and hemodynamic disease  Ramon Berguer, MD, PhD, Mark D. Morasch,

A review of 100 consecutive reconstructions of the distal vertebral artery for embolic and hemodynamic disease  Ramon Berguer, MD, PhD, Mark D. Morasch,
Heparin-coated catheters and heparin-induced thrombocytopenia

Heparin-coated catheters and heparin-induced thrombocytopenia
Elastin, collagen, and some mechanical aspects of arterial aneurysms

Elastin, collagen, and some mechanical aspects of arterial aneurysms
Axillary-to-carotid artery bypass grafting for symptomatic severe common carotid artery occlusive disease  Joseph P. Archie, PhD, MD  Journal of Vascular.

Axillary-to-carotid artery bypass grafting for symptomatic severe common carotid artery occlusive disease  Joseph P. Archie, PhD, MD  Journal of Vascular.
Lloyd M. Taylor, M.D., Edward S. Phinney, M.D., John M. Porter, M.D. 

Lloyd M. Taylor, M.D., Edward S. Phinney, M.D., John M. Porter, M.D. 
Development of a “leak-proof,” knitted Dacron vascular prosthesis

Development of a “leak-proof,” knitted Dacron vascular prosthesis
Mycotic axillary artery aneurysm

Mycotic axillary artery aneurysm
Descending thoracic aorta to iliofemoral artery bypass grafting: A role for primary revascularization for aortoiliac occlusive disease?  Marc A. Passman,

Descending thoracic aorta to iliofemoral artery bypass grafting: A role for primary revascularization for aortoiliac occlusive disease?  Marc A. Passman,
A new valvulotome for in situ bypass grafts

A new valvulotome for in situ bypass grafts
Axillofemoral bypass: A tool with a limited role

Axillofemoral bypass: A tool with a limited role
Long-term safety of cilostazol in patients with peripheral artery disease: The CASTLE study (Cilostazol: A Study in Long-term Effects)  William R. Hiatt,

Long-term safety of cilostazol in patients with peripheral artery disease: The CASTLE study (Cilostazol: A Study in Long-term Effects)  William R. Hiatt,
Differences in secretion of prostacyclin by venous and arterial endothelial cells grown in vitro in a static versus a mechanically active environment 

Differences in secretion of prostacyclin by venous and arterial endothelial cells grown in vitro in a static versus a mechanically active environment 
Malcolm O. Perry, MD, Richard Kempczinski, MD 

Malcolm O. Perry, MD, Richard Kempczinski, MD 
Recurrent thoracic outlet syndrome

Recurrent thoracic outlet syndrome

Similar presentations

Ads by Google